Ghaith Almhanni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ghaith Almhanni has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Jason Beckermann
Department of Surgery, Mayo Clinic Health System , 1400 Bellinger, Eau Claire, WI 54703
2 shared publications - Tiziano Tallarita
Department of Cardiovascular Surgery, Mayo Clinic Health System, Eau Claire, WI, USA
2 shared publications - Ahmad Abdulraheem
Department of Internal Medicine, MedStar Georgetown Washington Hospital Center, Washington, DC 20057, USA
1 shared publication - Bara Abujaber
Department of Internal Medicine, MedStar Washington Hospital Center, Washington, DC, USA
1 shared publication - Dania Qarkash
Department of Internal Medicine, School of Medicine, University of Jordan, Amman, Jordan
1 shared publication G. Krueger
1 shared publication
Latest Publications
- Open Access
- 30 March 2026
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 59 (2) , 211-222
Impact of glucagon-like peptide-1 receptor agonists on colonoscopy outcomes: a systematic review and meta-analysis
Background/Aims: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely prescribed for diabetes and obesity. Recent studies suggest they may negatively affect bowel preparation quality before colonoscopy (CLN), leading to inadequate bowel preparation (IBP) and repeat procedures. We conducted a systematic review and meta-analysis to assess this association.Methods: PubMed, Embase and Cochrane databases, along with abstracts from Digestive Disease Week 2024 and the American College of Gastroenterology Meeting 2024, were searched. Outcomes included IBP, repeat CLNs, and the mean difference in Boston Bowel Preparation Scale (BBPS) scores between GLP-1 RA users and non-users. Adjusted odds ratios (OR), for age, sex, body mass index, and diabetes, were pooled.Results: Twelve studies including 123,858 patients (57,699 GLP-1 RA users) were analyzed. GLP-1 RA use was associated with higher IBP risk (OR, 1.55; 95% CI, 1.11–2.16); adjusted analyses confirmed this (OR, 2.35; 95% CI, 2.02–2.74). BBPS scores were lower among GLP-1 RA users (mean difference, –0.68; 95% CI, –0.77 to –0.58). No association with repeat CLNs was observed (OR, 1.5; 95% CI, 0.88–2.56).Conclusions: GLP-1 RA use is linked to inadequate bowel preparation but not repeat CLNs. Further prospective studies are warranted to further evaluate this finding.
- 30 March 2026
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 59 (2) , 211-222
Open AccessImpact of glucagon-like peptide-1 receptor agonists on colonoscopy outcomes: a systematic review and meta-analysis
Background/Aims: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely prescribed for diabetes and obesity. Recent studies suggest they may negatively affect bowel preparation quality before colonoscopy (CLN), leading to inadequate bowel preparation (IBP) and repeat procedures. We conducted a systematic review and meta-analysis to assess this association.Methods: PubMed, Embase and Cochrane databases, along with abstracts from Digestive Disease Week 2024 and the American College of Gastroenterology Meeting 2024, were searched. Outcomes included IBP, repeat CLNs, and the mean difference in Boston Bowel Preparation Scale (BBPS) scores between GLP-1 RA users and non-users. Adjusted odds ratios (OR), for age, sex, body mass index, and diabetes, were pooled.Results: Twelve studies including 123,858 patients (57,699 GLP-1 RA users) were analyzed. GLP-1 RA use was associated with higher IBP risk (OR, 1.55; 95% CI, 1.11–2.16); adjusted analyses confirmed this (OR, 2.35; 95% CI, 2.02–2.74). BBPS scores were lower among GLP-1 RA users (mean difference, –0.68; 95% CI, –0.77 to –0.58). No association with repeat CLNs was observed (OR, 1.5; 95% CI, 0.88–2.56).Conclusions: GLP-1 RA use is linked to inadequate bowel preparation but not repeat CLNs. Further prospective studies are warranted to further evaluate this finding.
- 18 April 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 79 (5) , A17-A18
Midterm outcomes of endoscopic-assisted brachial-basilic arteriovenous fistula creation
- 18 April 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 79 (5) , A17-A18
Midterm outcomes of endoscopic-assisted brachial-basilic arteriovenous fistula creation
- Open Access
- 26 November 2023
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 10 (2) , 101382
Midterm outcomes of endoscopic-assisted brachial-basilic arteriovenous fistula creation
- 26 November 2023
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 10 (2) , 101382
Open AccessMidterm outcomes of endoscopic-assisted brachial-basilic arteriovenous fistula creation